Corrigendum to "WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM" [ Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369]

Zhiming Ye,Li Fan,Rui Yan,Bicheng Liu,Linghui Zhou,Guangqun Xing,Wei Zhao,Zunsong Wang,Deguang Wang,Min Zhang,Xin Zhang,Xinyu Yang,Xue Yang,Xueqing Yu
DOI: https://doi.org/10.1016/j.ekir.2024.06.005
2024-06-06
Abstract:[This corrects the article DOI: 10.1016/j.ekir.2024.02.771.].
What problem does this paper attempt to address?